Sidra Medicine, a member of Qatar Foundation, has highlighted the real-world impact of precision medicine on a six-year-old patient with a rare genetic condition. Marking Rare Disease Day observed ...
Scientists have unveiled a breakthrough way to turn natural gas—long burned as fuel—into valuable chemical building blocks for medicines and other high-demand products. By designing a clever ...
A growing body of research suggests the brain plays a central role in diabetic ketoacidosis, opening the possibility of treating type 1 diabetes in an entirely new way.
FDA grants Breakthrough Therapy designation to luvesilocin for postpartum depression following positive results from the phase 2 RECONNECT trial.
Scientists at Fred Hutch Cancer Center have reported an important advance in the effort to stop Epstein Barr virus (EBV), a virus believed to infect about 95% of people worldwide. EBV has been linked ...
Scientists in China have unveiled a breakthrough way to mass-produce powerful cancer-fighting immune cells in the lab. By ...
A research team from the Department of Obstetrics and Gynaecology at the School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has made a major breakthrough in ...
A breakthrough in insulin delivery could one day spell an end to the invasive needles on which many people with diabetes rely. Using mice, minipigs, and lab-grown human skin samples, scientists have ...
Emerging data investigate MRI brain screening for metastatic breast cancer patients. Duke Cancer Center's Carey Anders, MD, along with other leading medical experts, discusses the need for women to ...
The FDA granted breakthrough therapy designation to Rybrevant Faspro based on data from the phase 1b/2 OrigAMI-4 study (NCT06385080).
Hosted on MSN
Mind Medicine (MindMed) Inc. (MNMD)’s MM120 Earns FDA Breakthrough Status in Anxiety Treatment
We recently compiled a list of the 13 Best Psychedelic Stocks to Invest in Now. Mind Medicine (MindMed) Inc. stands fourth among them. Mind Medicine (MindMed) Inc. (NASDAQ:MNMD), a clinical-stage ...
Integration of genomic research yields targeted surgical intervention and personalized care program for a young patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results